Valuation: Anupam Rasayan India Ltd

Market Cap 138B 1.46B 1.26B 1.18B 1.08B 2.04B 2.06B 13.82B 5.42B 69.29B 5.47B 5.35B 229B P/E 2026
81.6x
P/E 2027 * 41.1x
Enterprise Value 144B 1.51B 1.31B 1.22B 1.12B 2.12B 2.14B 14.33B 5.62B 71.87B 5.67B 5.55B 238B EV / Sales 2026
6.55x
EV / Sales 2027 * 4.21x
Free-Float
16.06%
Yield 2026
0.12%
Yield 2027 * 0.16%
07-17 Anupam Rasayan India Ltd acquired Mates Visa Consultancy Private Limited for INR 0.01 million. CI
07-15 Anupam Rasayan India Limited Signs Letter Of Intent With BASQUEVOLT, S.A. For Potential Long-Term Supply Of Specialty Chemical Product Worth USD 300 Million CI
07-06 Tanfac Industries Limited announced that it expects to receive INR 1.734872962 billion in funding from Anupam Rasayan India Ltd, Alrox Enterprises Private Limited CI
06-11 Anupam Rasayan India Limited Commercialises ETFA Using Flow Chemistry CI
06-04 Crisil Places Anupam Rasayan Ratings on Watch Developing After Bliss GVS Acquisition Announcement MT
05-25 Anupam Rasayan India Ltd, Q4 2026 Earnings Call, May 25, 2026
05-23 Anupam Rasayan India Ltd Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
05-23 Anupam Rasayan India Limited Announces Resignation of Vishal Thakkar as Deputy Chief Financial Officer and Key Managerial Personnel, Effective May 23, 2026 CI
05-23 Anupam Rasayan India Ltd Recommends Final Dividend for the Financial Year 2025-26 CI
05-23 Anupam Rasayan India Ltd proposed to acquire 26.21% stake in Bliss GVS Pharma Limited for INR 8.3 billion. CI
05-23 Anupam Rasayan India Ltd proposed to acquire 26.21% stake in Bliss GVS Pharma Limited for INR 8.3 billion. CI
05-23 Anupam Rasayan India Ltd entered into a share purchase agreement to acquire 43.30% stake in Bliss GVS Pharma Limited for INR 13.7 billion. CI
02-27 Anupam Rasayan India Ltd completed the acquisition of Jayhawk Fine Chemicals Corporation from CABB Group GmbH. CI
1 day-0.27%
1 week+0.18%
Current month+0.43%
1 month-4.43%
3 months-10.84%
6 months-7.78%
Current year-8.03%
1 week 1,196
Extreme 1196
1,224
1 month 1,196
Extreme 1196
1,294.5
Current year 1,162.3
Extreme 1162.3
1,415
1 year 1,045.2
Extreme 1045.2
1,415
3 years 601
Extreme 601
1,415
5 years 546.75
Extreme 546.75
1,415
10 years 474
Extreme 474
1,415
Manager TitleAgeSince
Chief Executive Officer - 11/09/2023
Director of Finance/CFO 36 15/03/2022
Chief Operating Officer 54 23/02/2021
Director TitleAgeSince
Chairman 50 23/04/2013
Director/Board Member 52 01/01/1992
Chairman 77 31/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.27%+0.18%+6.83%+30.97% 1.46B
+0.82%+0.62%+7.13%+56.40% 80.34B
+0.75%+4.50%+0.67%+19.48% 38.91B
+0.69%+9.45%+3.77%-27.39% 38.85B
+1.31%+1.23%+19.58%+45.21% 28.81B
+0.49%+0.49%+28.85%+15.65% 23.73B
+2.14%+3.70%+93.88%-1.41% 20.01B
+3.11%+6.71%-32.34%-36.23% 19.9B
+1.10%+0.50%+16.21%-0.30% 14.44B
-1.64%+4.36%+74.12%-40.61% 14.02B
Average +0.97%+3.08%+21.87%+6.18% 28.05B
Weighted average by Cap. +0.94%+2.98%+16.09%+16.48%

Financials

2026 2027 *
Net sales 22.24B 234M 203M 189M 174M 328M 332M 2.22B 871M 11.13B 878M 859M 36.85B 37.23B 392M 339M 316M 291M 549M 555M 3.71B 1.46B 18.63B 1.47B 1.44B 61.7B
Net income 1.59B 16.71M 14.47M 13.49M 12.41M 23.43M 23.69M 159M 62.23M 795M 62.76M 61.38M 2.63B 3.37B 35.43M 30.69M 28.61M 26.31M 49.67M 50.22M 336M 132M 1.69B 133M 130M 5.58B
Net Debt 5.16B 54.26M 46.99M 43.8M 40.29M 76.06M 76.91M 515M 202M 2.58B 204M 199M 8.55B 18.21B 191M 166M 155M 142M 268M 271M 1.82B 713M 9.11B 719M 703M 30.17B
Logo Anupam Rasayan India Ltd
Anupam Rasayan India Ltd. is an India-based company, which is engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals. The Company's segments include Life Science related Specialty Chemicals and Other Specialty Chemicals. The Life Science related Specialty Chemicals segment includes agrochemicals (including crop protection), personal care, and pharmaceuticals businesses. Its agrochemicals business includes manufacturing agro intermediates and active ingredients, such as insecticides, fungicides, herbicides and plant growth regulators. Its personal care business manufactures antibacterial and ultraviolet protection intermediates. Its pharmaceuticals business develops intermediates and key starting materials for active pharmaceutical ingredients used in therapeutic segments, including cardiovascular and antidiabetic. The Other Specialty Chemicals segment includes specialty pigments, specialty dyes, and polymer additives. It caters to Indian and global customers.
Employees
2,606
Date Price Change Volume
06/08/26 1,213.00 -0.27% 88,592
05/08/26 ₹1,216.30 +0.16% 138,524
04/08/26 ₹1,214.40 +0.38% 234,655
03/08/26 ₹1,209.80 +0.17% 199,378
31/07/26 ₹1,207.80 -0.25% 143,529
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
1,216.30INR
Average target price
1,143.00INR
Spread / Average Target
-6.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ANURAS Stock